Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders - Effects on bone mineral density

Journal of Affective Disorders

Volumn 136, Issue 1-2, 2012, Pages

  Ricken, Roland ^a   Bermpohl, Felix ^a,b   Schlattmann, Peter ^c   Bschor, Tom ^d   Adli, Mazda ^a   Mönter, Norbert ^d   Bauer, Michael ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin School of Mind and Brain   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d Department of Psychiatry and Psychotherapy ^*  (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Absorptiometry; Affective disorders; Bone mineral density; Dual energy X ray; Levothyroxine; Prophylaxis

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; HORMONAL THERAPY; HUMAN; LONG TERM CARE; LUMBAR SPINE; MALE; MOOD DISORDER; OSTEOLYSIS; OSTEOPOROSIS; PATIENT MONITORING; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; THYROXINE;

EID: 84857046697     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.06.011     Document Type: Article

References (23)

1. J.E. Adams Single and dual energy X-ray absorptiometry Eur. Radiol. 7 Suppl. 2 1997 20 31
2. D.T. Baran The skeletal system in thyrotoxicosis L.E. Braverman, R.D. Utiger, The Thyroid. A Fundamental and Clinical Text 8th ed. 2000 Lippincott Raven, Philadelphia 659 666
3. M.S. Bauer, and P.C. Whybrow Rapid cycling bipolar affective disorders II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study Arch. Gen. Psychiatry 47 1990 43 440
4. M. Bauer, R. Hellweg, K.J. Gräf, and A. Baumgartner Treatment of refractory depression with high dose thyroxine Neuropsychopharmacology 18 1998 444 455 (Pubitemid 28202352)
5. M. Bauer, A. Berghoeffer, T. Bschor, A. Baumgartner, U. Kiesslinger, R. Hellweg, M. Adli, C. Baethge, and B. Mueller-Oerlinghausen Supraphysiological doses of thyroxine in the maintenance treatment of prophylaxis resistant affective disorders Neuropsychopharmacology 27 2002 620 628
6. M. Bauer, H. Baur, A. Berghöfer, A. Ströhle, R. Hellweg, B. Müller-Oerlinghausen, and A. Baumgartner Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders J. Affect. Disord. 68 2-3 2002 285 294 (2002 Apr) (Pubitemid 34628334)
7. M. Bauer, M. Adli, T. Bschor, A. Heinz, N. Rasgon, M. Frye, H. Grunze, R. Kupka, and P.C. Whybrow Clinical applications of levothyroxine in refractory mood disorders Clin. Appl. Bipolar Disord. 2 2003 49 56
8. M. Bauer, L. Fairbanks, A. Berghöfer, J. Hierholzer, T. Bschor, C. Baethge, N. Rasgon, J. Sasse, and P.C. Whybrow Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study J. Affect. Disord. 83 2-3 2004 183 189
9. M. Bauer, E.D. London, N. Rasgon, S.M. Berman, M.A. Frye, L. Altshuler, M.A. Mandelkern, J. Bramen, R. Woods, J.C. Mazziotta, and P.C. Whybrow Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in women with bipolar depression Mol. Psychiatry 10 2005 456 469 (Pubitemid 40646434)
10. M. Bauer, T. Goetz, T. Glenn, and P.C. Whybrow The thyroid-brain interaction in thyroid disorders and mood disorders J. Neuroendocrinol. 20 2008 1101 1114
11. B. Biondi, and D.S. Cooper Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer Thyroid 20 2 2010 135 146
12. P.W. Gold, F.K. Goodwin, and G.P. Chrousos Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N. Engl. J. Med. 319 1988 413 420
13. S.L. Greenspan, and F.S. Greenspan The effect of thyroid hormone on skeletal integrity Ann. Intern. Med. 130 1999 750 758 (Pubitemid 29211514)
14. S.L. Greenspan, F.S. Greenspan, N.M. Resnick, J.E. Block, A.L. Friedlander, and H.K. Genant Skeletal integrity in premenopausal and postmenopausal women receiving long-term l-thyroxine therapy Am. J. Med. 91 1991 5 14
15. L. Gyulai, J. Jaggi, M.S. Bauer, S. Younkin, L. Rubin, M. Attie, and P.C. Whybrow Bone mineral density and l-thyroxine treatment in rapidly cycling bipolar disorder Biol. Psychiatry 41 1997 503 506 (Pubitemid 27087336)
16. L. Gyulai, M. Bauer, F. Espana-Garcia, J. Hierholzer, A. Baumgartner, A. Berghöfer, and P.C. Whybrow Bone mineral density in pre- and post-menopausal women with affective disorder treated with long-term l-thyroxine augmentation J. Affect. Disord. 66 2001 185-19
17. Lunar Corporation Technical manual. Documentation version 7/91 DPX-L Software Version 1.2 1991 Lunar Corporation Madison, Wisconsin
18. D. Michelson, C. Stratakis, L. Hill, J. Reynolds, E. Galliven, G. Chrousos, and P. Gold Bone mineral density in women with depression N. Engl. J. Med. 335 1996 1176 1181 (Pubitemid 26339771)
19. L. Mosekilde, E.F. Eriksen, and P. Charles Effects of thyroid hormones on bone and mineral metabolism Endocrinol. Metab. Clin. N. Am. 19 1990 35 63 (Pubitemid 20142107)
20. V. O' Keane Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia J. Psychopharmacol. 22 2008 70 75
21. J.B. Richards, A. Papaioannou, and J.D. Adachi Effect of selective serotonin reuptake inhibitors on the risk of fracture Arch. Intern. Med. 167 2007 188 194 (Pubitemid 46148067)
22. R. Schneider, and C. Reiners The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature Exp. Clin. Endocrinol. Diabetes 111 8 2003 455 470 (Pubitemid 38101490)
23. P. Vestergaard, L. Rejnmark, and L. Mosekilde Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture Osteoporos. Int. 17 2006 807 816 (Pubitemid 43781493)